chives of Pharmacology, 363, 139-145. doi:10.1007/s002100000346
  • Puig, M.V., Santana, N., Celada, P., Mengod, G. and Artigas, F. (2004) In vivo excitation of GABA interneurons in the medial prefrontal cortex through 5-HT3 receptors. Cerebral Cortex, 14, 1365-1375. doi:10.1093/cercor/bhh097
  • Grider, J.R. (2006) Desensitization of the peristaltic reflex induced by mucosal stimulation with the selective 5-HT4 agonist tegaserod. American Journal of Physiology-Gastrointestinal and Liver Physiology, 290, G319- G327. doi:10.1152/ajpgi.00326.2005
  • Mialet, J., Fischmeister, R. and Lezoualc’h, F. (2003) Characterization of human 5-HT4(d) receptor desensitization in CHO cells. British Journal of Pharmacology, 138, 445-452. doi:10.1038/sj.bjp.0705061
  • Lefebvre, H., et al. (1998) Effect of prolonged administration of the serotonin4 (5-HT4) receptor agonist cisapride on aldosterone secretion in healthy volunteers. Endocrine Research, 24, 749-752. doi:10.3109/07435809809032681
  • Ouchi, Y., et al. (2009) Altered brain serotonin transporter and associated glucose metabolism in Alzheimer disease. The Journal of Nuclear Medicine, 50, 1260-1266. doi:10.2967/jnumed.109.063008
  • Hendricksen, M., Thomas, A., Ferrier, I.N., Ince, P. and O’Brien, J. (2004) Neuropathological study of the dorsal raphe nuclei in late-life depression and Alzheimer’s disease with and without depression. American Journal of Psychiatry, 161, 1096-1102. doi:10.1176/appi.ajp.161.6.1096
  • Journal Menu >>